Calithera Biosciences Inc (CALA.OQ)
CALA.OQ on NASDAQ Stock Exchange Global Select Market
4.84USD
8:59pm GMT
4.84USD
8:59pm GMT
Change (% chg)
$-0.02 (-0.41%)
$-0.02 (-0.41%)
Prev Close
$4.86
$4.86
Open
$4.91
$4.91
Day's High
$4.95
$4.95
Day's Low
$4.71
$4.71
Volume
30,527
30,527
Avg. Vol
69,289
69,289
52-wk High
$9.75
$9.75
52-wk Low
$4.07
$4.07
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.00 | -0.518 |
| Jun '18 | 17.07 | -0.086 | |
| Mar '18 | 5.19 | -0.369 | |
| FY 2017 | Dec '17 | 7.25 | -0.308 |
| Sep '17 | 7.25 | -0.171 | |
| Jun '17 | 7.26 | -0.147 | |
| Mar '17 | 4.19 | -0.221 | |
| FY 2016 | Dec '16 | 0.00 | -0.452 |
| Sep '16 | 0.00 | -0.438 | |
| Jun '16 | 0.00 | -0.546 | |
| Mar '16 | 0.00 | -0.521 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 4 | 1.73 | 6.90 | 0.00 | 6.90 |
| Quarter Ending Mar-19 | 2 | 3.00 | 6.00 | 0.00 | -- |
| Year Ending Dec-18 | 4 | 24.01 | 29.20 | 22.25 | 24.47 |
| Year Ending Dec-19 | 4 | 13.00 | 28.00 | 0.00 | 9.79 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 5 | -0.49 | -0.34 | -0.58 | -0.20 |
| Quarter Ending Mar-19 | 2 | -0.47 | -0.39 | -0.56 | -0.41 |
| Year Ending Dec-18 | 5 | -1.44 | -1.32 | -1.55 | -1.08 |
| Year Ending Dec-19 | 5 | -2.05 | -1.39 | -3.22 | -2.47 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 92.25 | 33.63 | |
| P/E High - Last 5 Yrs. | -- | 323.37 | 45.43 | |
| P/E Low - Last 5 Yrs. | -- | 90.29 | 24.43 | |
| Beta | -- | 0.91 | 0.90 | |
| Price to Sales (TTM) | 53.46 | 116.41 | 5.77 | |
| Price to Book (MRQ) | 3.76 | 15.60 | 5.12 | |
| Price to Tangible Book (MRQ) | 3.77 | 14.89 | 6.54 | |
| Price to Cash Flow (TTM) | -- | 72.75 | 23.57 | |
| % Owned Institutions | 90.00 | 12.59 | 1.83 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.39 | 1.49 | |
| Dividend Yield - 5 Year Avg | -- | 0.31 | 1.50 | |
| Dividend 5 Year Growth Rate | -- | 2.65 | 5.08 | |
| Payout Ratio(TTM) | -- | 23.68 | 43.75 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 358.89 | 7.43 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 90.38 | 5.80 | |
| Sales - 5 Yr. Growth Rate | -- | 31.32 | 10.18 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 73.06 | 36.71 | 21.03 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 37.17 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 39.68 | 10.79 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 39.59 | 15.12 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.98 | 2.28 |
| Current Ratio (MRQ) | 4.95 | 5.42 | 3.11 |
| LT Debt to Equity (MRQ) | 0.00 | 33.58 | 11.47 |
| Total Debt to Equity (MRQ) | 0.00 | 35.41 | 15.63 |
| Interest Coverage (TTM) | -- | -152.90 | 31.38 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 41.87 | 54.20 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.14 | 51.98 | |
| EBITD Margin (TTM) | -256.99 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -506.72 | 11.83 | |
| Operating Margin (TTM) | -259.69 | -728.64 | 4.90 | |
| Operating Margin - 5 Yr. Avg. | -- | -526.20 | 7.44 | |
| Pre-Tax Margin (TTM) | -251.99 | -694.91 | 5.91 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -531.06 | 7.89 | |
| Net Profit Margin (TTM) | -251.99 | -696.69 | 2.16 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -534.51 | 4.12 | |
| Effective Tax Rate (TTM) | -- | 25.12 | 23.36 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 20.63 | 24.15 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 228,940 | 25,687,735 | 898,898,415 | |
| Net Income/Employee (TTM) | -576,900 | 2,194,099 | 106,547,429 | |
| Receivable Turnover (TTM) | -- | 18.46 | 5.94 | |
| Inventory Turnover (TTM) | -- | 2.61 | 3.62 | |
| Asset Turnover (TTM) | 0.08 | 0.43 | 0.97 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -20.80 | -1.11 | 11.50 | |
| Return on Assets - 5 Yr. Avg. | -- | 2.88 | 12.67 | |
| Return on Investment (TTM) | -24.22 | 0.29 | 15.02 | |
| Return on Investment - 5 Yr. Avg. | -- | 1.84 | 16.45 | |
| Return on Equity (TTM) | -26.14 | 0.94 | 16.60 | |
| Return on Equity - 5 Yr. Avg. | -- | 2.30 | 17.56 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -7.81 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Calithera Biosciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 6.15 | 2.49 | 60 | 57 |
| 13 Week | -3.63 | -8.32 | 43 | 61 |
| 26 Week | 53.33 | 41.68 | 83 | 81 |
| 52 Week | 429.14 | 348.49 | 98 | 47 |
| YTD | 430.77 | 366.12 | 99 | 60 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 65.01% |
| # of Holders: | 122 |
| Total Shares Held: | 24,784,033 |
| 3 Mo. Net Change: | -32,310 |
| # New Positions: | 14 |
| # Closed Positions: | 21 |
| # Increased Positions: | 47 |
| # Reduced Positions: | 51 |
| # Net Buyers: | -4 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.